FNSUR - Overview: NASH FibroSure

Test Catalog

Test Name

Test ID: FNSUR    
NASH FibroSure

Useful For Suggests clinical disorders or settings where the test may be helpful

This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Quantitative results of 10 biochemicals in combination with age, gender, height and weight are analyzed using a computational algorithm to provide a quantitative surrogate marker (0.0-1.0) of liver fibrosis (Metavir F0-F4), hepatic steatosis (0.0-1.0, S0-S3), and nonalcoholic steatohepatitis (NASH) (0.0-0.75, N0-N2). The absence of steatosis (S<0.38) precludes the diagnosis of NASH.

Method Name A short description of the method used to perform the test

FibroSURE

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name A shorter or abbreviated version of the Published Name for a test; an abbreviated test name

NASH FibroSure

Aliases Lists additional common names for a test, as an aid in searching

Fatty Liver Disease FORWARD
NAFLD FORWARD
Nonalcoholic Fatty Liver Disease FORWARD
Noninvasive Liver Biopsy FORWARD
Steatohepatitis FORWARD